West Pharmaceutical Services Inc (WST) financials

West Pharmaceutical Services Inc (WST) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, West Pharmaceutical Services Inc reported revenue of $3.07B, up 6.3% year over year, net income of $494M, diluted EPS of $6.79 and free cash flow of $469M.

Revenue (fiscal 2025)

$3.07B

Revenue growth (fiscal 2025)

6.3%

Net income (fiscal 2025)

$494M

Diluted EPS (fiscal 2025)

$6.79

Free cash flow (fiscal 2025)

$469M

West Pharmaceutical Services Inc files with the U.S. Securities and Exchange Commission under CIK 0000105770, classified as Surgical & Medical Instruments & Apparatus.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.